Walk in Interview for M.Pharm, M.Sc in Cancer Therapy research at RCB | Government of India
Regional Centre for Biotechnology (RCB), an institution of education, training and research is established by the Department of Biotechnology, Government of India under the auspices of UNESCO. The Centre will focus on cooperatively working towards shared biotechnology growth in the Asia-Pacific Region. Regional interactions in biotechnology will promote co-operation amongst the countries to develop necessary infrastructure and capacity building for economic benefit of our societies. The Centre would be beneficial in developing knowledge rich, highly skilled human resource to all countries in the region. RCB will be part of the Biotech Science Cluster (BSC) and will operate in synergy with the other institutions in the Cluster.
Post : Project - JRF

Glenmark Pharmaceuticals Ltd. is one of India’s leading research-driven, global, integrated pharmaceutical company.Glenmark has Offices in over 40 Countries. It has 17 manufacturing facilities in 5 countries, with over 12,000 employees from over 60 nationalities, 5 world-class research and development centre, the group is dedicated to improving people’s live.
Defence Research & Development Organisation (DRDO) works under Department of Defence Research and Development of Ministry of Defence. DRDO dedicatedly working towards enhancing self-reliance in Defence Systems and undertakes design & development leading to production of world class weapon systems and equipment in accordance with the expressed needs and the qualitative requirements laid down by the three services. DRDO is working in various areas of military technology which include aeronautics, armaments, combat vehicles, electronics, instrumentation engineering systems, missiles, materials, naval systems, advanced computing, simulation and life sciences. DRDO while striving to meet the Cutting edge weapons technology requirements provides ample spinoff benefits to the society at large thereby contributing to the nation building.
Clinical Development Services Agency (CDSA) is an extramural unit of Translational Health Science and Technology Institute which is an autonomous institute created by the Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India to strengthen the existing clinical trial / study capacity for affordable health care products in India and raise it to international standards. It is committed to strengthening and expanding the evidence base for healthcare nationally. CDSA has a national reputation for assisting academic investigators, bio-pharma entrepreneurs and innovative SMEs in the delivery of clinical trials and cohort studies throughout their life cycle from set up to closure. Over time, and building on current strengths, the mission of the Clinical Portfolio Section of CDSA is to become a centre of excellence that supports the conduct of Phase III/IV clinical trials and epidemiological studies of national importance.


